Onglyza Lawsuits Exceed 200 as Claims of Cardiovascular Injury Grow
On June 15th, the Judicial Panel on Multidistrict Litigation (JPML) issued a report on pending MDL dockets currently active in all U.S. District Courts. The…
Health
Hernia Mesh Problems Continue into 2018
It was not far into the New Year when Ethicon, Inc.—a Johnson & Johnson subsidiary—was named in a hernia mesh lawsuit filed in Idaho by…
Nuedexta: Did Greed Push this Pill’s Popularity?
Avanir Pharmaceuticals manufactures Nuedexta, a prescription drug medication approved by the Food and Drug Administration (FDA) to treat a rare condition—pseudobulbar affect (PBA)—where sufferers experience…
New Study Says Heart Stents Are Ineffective for Pain
According to the Centers for Disease Control and Prevention (CDC), about 735,000 people suffer a heart attack each year in the U.S.—making heart disease the…
Could New FDA Commissioner Lift Drug Label Restrictions?
While the Food and Drug Administration (FDA) is charged with supervising a wide array of public health concerns that include blood transfusions, radiation-emitting devices, tobacco…
Risperdal Trials Set for Next Month as Number of New Cases Continues to Grow
Mass tort cases continue to pile up for Johnson & Johnson (J&J) and their subsidiaries. So is the case with Risperdal, a treatment for bipolar…
Invokana Called into Question with Latest FDA Warning
When Invokana was first approved by the Food and Drug Administration (FDA) in 2013, it commenced a new class of diabetes treatment. Specifically known as…
Hernia Mesh Cases Move Forward with MDL
In December, I wrote a blog discussing the likelihood of MultiDistrict Litigation (MDL) for two manufacturers of a hernia mesh surgical device—Atrium Medical who produces…
Hyland’s Products Could Still Harm Your Baby
On October 11, 2016, homeopathic medicine manufacturer Hyland’s issued a public letter to parents everywhere. Beginning with “Dear Moms and Dads…” the corporate communication went…